Brightstar Therapeutics Revenue and Competitors
Employee Data
- Brightstar Therapeutics has 53749 Employees.
- Brightstar Therapeutics grew their employee count by 12% last year.
Brightstar Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
Brightstar Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $35M | 111 | 8% | N/A | N/A |
#2 | N/A | 85 | 27% | N/A | N/A |
#3 | N/A | 127 | -3% | N/A | N/A |
#4 | N/A | 957 | 28% | N/A | N/A |
#5 | $75M | 3809 | 5% | N/A | N/A |
#6 | N/A | 68 | 28% | N/A | N/A |
#7 | N/A | 33 | 57% | N/A | N/A |
#8 | N/A | 53749 | 12% | N/A | N/A |
#9 | N/A | 28 | 27% | N/A | N/A |
#10 | N/A | 152 | 23% | N/A | N/A |
What Is Brightstar Therapeutics?
Brightstar Therapeutics is a biotechnology company focused on providing innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. \n\nBrightstar Therapeutics is the first company to offer a long-term solution for persistent epithelial defects, and partial limbal stem cell deficiency through its advanced corneal allograft, BrightMEM.
keywords:N/A
N/A
Total Funding
53749
Number of Employees
N/A
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator